888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
OV484Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores
Cores48Cases48
Row number6Column number8
Core Diameter(mm)2.0Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:OV484
 
Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores
 
Price: $195.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (III)
 
Malignant (IV)
TISSUE  ARRAYS OV484
1
2
3
4
5
6
7
8
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1157FOvarySerous papillary adenocarcinoma1--2T1bN0M0IBMalignant
A2225FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A3364FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A4441FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A5548FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A6657FOvarySerous papillary adenocarcinoma1T1cN0M0ICMalignant
A7770FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignant
A8855FOvarySerous papillary adenocarcinoma (fibrofatty tissue)*T1aN0M0IAMalignant
B1952FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
B21069FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B31156FOvarySerous papillary adenocarcinoma (sparse)2T1bN0M0IBMalignant
B41257FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
B51342FOvarySerous papillary adenocarcinoma2T1cN0M0ICMalignant
B61454FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignant
B71541FOvarySerous papillary adenocarcinoma2T2N0M0IIAMalignant
B81649FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant
C11773FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
C21857FOvarySerous papillary adenocarcinoma3T3N0M0IIIMalignant
C31953FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
C42047FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
C52166FOvarySerous papillary adenocarcinoma3T1cN0M0ICMalignant
C62252FOvarySerous papillary adenocarcinoma3T1cN0M0ICMalignant
C72355FOvarySerous papillary adenocarcinoma3T1bN0M0IBMalignant
C82458FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
D12555FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
D22664FOvarySerous papillary adenocarcinoma (sparse)2T1cN0M0ICMalignant
D32745FOvarySerous papillary adenocarcinoma3T1aN0M0IAMalignant
D42848FOvarySerous papillary adenocarcinoma3T2aN0M0IIAMalignant
D52956FOvarySerous papillary adenocarcinoma3T2N0M0IIMalignant
D63048FOvarySerous papillary adenocarcinoma (sparse) with necrosis3T3N1M1IVMalignant
D73156FOvarySerous papillary adenocarcinoma3T2N0M0IIMalignant
D83239FOvarySerous papillary adenocarcinoma3T2N0M0IIMalignant
E13360FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
E23440FOvarySerous papillary adenocarcinoma3T1N0M0IMalignant
E33552FOvaryMucinous papillary cystadenocarcinoma1T1aN0M0IAMalignant
E43661FOvaryMucinous papillary cystadenocarcinoma1T1aN0M0IAMalignant
E53748FOvaryMucinous papillary cystadenocarcinoma1--2T1N0M0IMalignant
E63846FOvarySerous papillary adenocarcinoma2T1N0M0IMalignant
E73952FOvaryEndometrioid adenocarcinoma1T1bN0M0IBMalignant
E84067FOvaryMucinous papillary cystadenocarcinoma3T1aN0M0IAMalignant
F14145FOvarySquamous cell carcinoma from malignant transformation of teratoma2T3cN1M1IVMalignant
F24251FOvarySquamous cell carcinoma from malignant transformation of teratoma3T1bN0M0IBMalignant
F34352FOvarySquamous cell carcinoma from malignant transformation of teratoma3T1aN0M0IAMalignant
F44473FOvaryGranular cell tumor*T1bN0M0IBMalignant
F54564FOvaryGranular cell tumor*T1aN0M0IAMalignant
F64650FOvaryGranular cell tumor*T1bN0M0IBMalignant
F74749FOvaryClear cell carcinoma*T1N0M0IMalignant
F84832FOvaryEndodermal sinus carcinoma*T1bN0M0IBMalignant
Tissue Marker
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs